BIOMAT Database Logo BIOMAT Database Logo

Compositional lipoprotein changes and low-density lipoprotein susceptibility to oxidation in chronic renal failure patients with heavy proteinuria. 2003

Sonia Athena Karabina, and Haralampos Pappas, and George Miltiadous, and Eleni Bairaktari, and Dimitris Christides, and Alexandros Tselepis, and Moses Elisaf, and Konstantinos Siamopoulos
Department of Chemistry, Laboratory of Biochemistry, Medical School, University of Ioannina, Ioannina, Greece.

BACKGROUND There are limited data regarding qualitative lipoprotein abnormalities in undialysed uremic patients without proteinuria. In this report, we focused on lipoprotein changes observed in uremic patients with proteinuria as well as on the susceptibility of low-density lipoprotein (LDL) of these patients to oxidative modification in vitro. METHODS 20 patients with chronic renal failure [serum creatinine >1.6 mg/dl (141.4 micromol/l)], but not yet on renal replacement therapy, and with heavy proteinuria (>2 g/24 h), and 18 age- and sex-matched healthy individuals participated in the study. In both patients and controls, venous blood was collected for determination of serum lipid and lipoprotein levels, lipoprotein subfraction profile and chemical composition, as well as the susceptibility of LDL subfractions to oxidation. RESULTS Patients exhibited a more atherogenic lipid profile compared with the control population. Furthermore, the total very LDL + intermediate-density lipoprotein mass was increased in patients compared with controls, while this subfraction was triglyceride enriched in uremic patients. The total LDL concentration was significantly higher in patients compared with controls due mainly to an increase in the mass of all lipoprotein subfractions. It is noteworthy that the mass of small dense LDL was significantly elevated in patients compared with controls (135 +/- 12 vs. 115 +/- 11 mg/dl, p = 0.01), an increase which was more pronounced in hypertriglyceridemic patients. Furthermore, the subfraction high-density lipoprotein-2 mass was significantly lower in uremic patients compared with controls. Finally, no significant differences in the lag time, the rate of oxidation and the relative electrophoretic mobility values in each LDL subfraction between the two groups were observed. CONCLUSIONS We conclude that uremic patients with heavy proteinuria exhibit compositional lipoprotein changes that are less marked than those observed in nonuremic patients with nephrotic syndrome. However, there is no evidence that circulating LDL isolated from these patients is more susceptible to oxidation in vitro than lipoprotein isolated from age- and gender-matched controls.

UI MeSH Term Description Entries
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008055 Lipids A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids (lipochromes), and fatty acids. (Grant & Hackh's Chemical Dictionary, 5th ed) Lipid
D008074 Lipoproteins Lipid-protein complexes involved in the transportation and metabolism of lipids in the body. They are spherical particles consisting of a hydrophobic core of TRIGLYCERIDES and CHOLESTEROL ESTERS surrounded by a layer of hydrophilic free CHOLESTEROL; PHOSPHOLIPIDS; and APOLIPOPROTEINS. Lipoproteins are classified by their varying buoyant density and sizes. Circulating Lipoproteins,Lipoprotein,Lipoproteins, Circulating
D008075 Lipoproteins, HDL A class of lipoproteins of small size (4-13 nm) and dense (greater than 1.063 g/ml) particles. HDL lipoproteins, synthesized in the liver without a lipid core, accumulate cholesterol esters from peripheral tissues and transport them to the liver for re-utilization or elimination from the body (the reverse cholesterol transport). Their major protein component is APOLIPOPROTEIN A-I. HDL also shuttle APOLIPOPROTEINS C and APOLIPOPROTEINS E to and from triglyceride-rich lipoproteins during their catabolism. HDL plasma level has been inversely correlated with the risk of cardiovascular diseases. High Density Lipoprotein,High-Density Lipoprotein,High-Density Lipoproteins,alpha-Lipoprotein,alpha-Lipoproteins,Heavy Lipoproteins,alpha-1 Lipoprotein,Density Lipoprotein, High,HDL Lipoproteins,High Density Lipoproteins,Lipoprotein, High Density,Lipoprotein, High-Density,Lipoproteins, Heavy,Lipoproteins, High-Density,alpha Lipoprotein,alpha Lipoproteins
D008077 Lipoproteins, LDL A class of lipoproteins of small size (18-25 nm) and light (1.019-1.063 g/ml) particles with a core composed mainly of CHOLESTEROL ESTERS and smaller amounts of TRIGLYCERIDES. The surface monolayer consists mostly of PHOSPHOLIPIDS, a single copy of APOLIPOPROTEIN B-100, and free cholesterol molecules. The main LDL function is to transport cholesterol and cholesterol esters to extrahepatic tissues. Low-Density Lipoprotein,Low-Density Lipoproteins,beta-Lipoprotein,beta-Lipoproteins,LDL(1),LDL(2),LDL-1,LDL-2,LDL1,LDL2,Low-Density Lipoprotein 1,Low-Density Lipoprotein 2,LDL Lipoproteins,Lipoprotein, Low-Density,Lipoproteins, Low-Density,Low Density Lipoprotein,Low Density Lipoprotein 1,Low Density Lipoprotein 2,Low Density Lipoproteins,beta Lipoprotein,beta Lipoproteins
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010084 Oxidation-Reduction A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs (Lehninger, Principles of Biochemistry, 1982, p471). Redox,Oxidation Reduction
D011507 Proteinuria The presence of proteins in the urine, an indicator of KIDNEY DISEASES. Proteinurias
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol

Related Publications

Sonia Athena Karabina, and Haralampos Pappas, and George Miltiadous, and Eleni Bairaktari, and Dimitris Christides, and Alexandros Tselepis, and Moses Elisaf, and Konstantinos Siamopoulos
Oxidation of low-density lipoprotein and atherosclerosis in chronic renal failure.
November 1997, Medical hypotheses,
Sonia Athena Karabina, and Haralampos Pappas, and George Miltiadous, and Eleni Bairaktari, and Dimitris Christides, and Alexandros Tselepis, and Moses Elisaf, and Konstantinos Siamopoulos
Low-density lipoprotein clearance in patients with chronic renal failure.
July 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
Sonia Athena Karabina, and Haralampos Pappas, and George Miltiadous, and Eleni Bairaktari, and Dimitris Christides, and Alexandros Tselepis, and Moses Elisaf, and Konstantinos Siamopoulos
[Changes in low density lipoprotein susceptibility to oxidation after wine ingestion].
October 1998, Medicina clinica,
Sonia Athena Karabina, and Haralampos Pappas, and George Miltiadous, and Eleni Bairaktari, and Dimitris Christides, and Alexandros Tselepis, and Moses Elisaf, and Konstantinos Siamopoulos
Decreased clearance of low-density lipoprotein in patients with chronic renal failure.
February 1994, Kidney international,
Sonia Athena Karabina, and Haralampos Pappas, and George Miltiadous, and Eleni Bairaktari, and Dimitris Christides, and Alexandros Tselepis, and Moses Elisaf, and Konstantinos Siamopoulos
Increased atherogenicity of low-density lipoprotein in heavy proteinuria.
May 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
Sonia Athena Karabina, and Haralampos Pappas, and George Miltiadous, and Eleni Bairaktari, and Dimitris Christides, and Alexandros Tselepis, and Moses Elisaf, and Konstantinos Siamopoulos
Low-density lipoprotein oxidizability in children with chronic renal failure.
August 2008, Pediatrics international : official journal of the Japan Pediatric Society,
Sonia Athena Karabina, and Haralampos Pappas, and George Miltiadous, and Eleni Bairaktari, and Dimitris Christides, and Alexandros Tselepis, and Moses Elisaf, and Konstantinos Siamopoulos
Low-density lipoprotein subfraction profiles in chronic renal failure.
September 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association,
Sonia Athena Karabina, and Haralampos Pappas, and George Miltiadous, and Eleni Bairaktari, and Dimitris Christides, and Alexandros Tselepis, and Moses Elisaf, and Konstantinos Siamopoulos
Assessment of susceptibility of low-density lipoprotein to oxidation.
January 2000, Methods in molecular medicine,
Sonia Athena Karabina, and Haralampos Pappas, and George Miltiadous, and Eleni Bairaktari, and Dimitris Christides, and Alexandros Tselepis, and Moses Elisaf, and Konstantinos Siamopoulos
Compositional and functional changes of low-density lipoprotein during hemodialysis in patients with ESRD.
August 1998, Kidney international,
Sonia Athena Karabina, and Haralampos Pappas, and George Miltiadous, and Eleni Bairaktari, and Dimitris Christides, and Alexandros Tselepis, and Moses Elisaf, and Konstantinos Siamopoulos
Susceptibility of low density lipoprotein to oxidation in familial hypercholesterolaemia.
May 1995, Atherosclerosis,
Copied contents to your clipboard!